Vizsgálati helyszín
Hacettepe Universitesi Tip Fakultesi
Ankara, 06230, TörökországMég nincs intézményhez kötve
- 7futó vizsgálat
- 8lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 15 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis13 vizsgálat
- 4. fázis1 vizsgálat
- Állapot
- Lezárult7 vizsgálat
- Fut, nem toboroz3 vizsgálat
- Még nem toboroz2 vizsgálat
- Toboroz2 vizsgálat
- Visszavonták1 vizsgálat
- Fő szponzor
- Bayer7 vizsgálat
- Boehringer Ingelheim2 vizsgálat
- Viridian Therapeutics, Inc.2 vizsgálat
- Amgen1 vizsgálat
- Janssen Research & Development, LLC1 vizsgálat
- és még 2
Futó vizsgálatok
Toboroz
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
NCT07192952· 3. fázis· Bayer· Forrás
Toboroz
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
NCT07188805· 3. fázis· Bayer· Forrás
Toboroz
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
NCT06632457· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
NCT05196035· 3. fázis· Bayer· Forrás
Fut, nem toboroz
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)
NCT04597125· 4. fázis· Bayer· Forrás
Toboroz
The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients
NCT04405583· Occlutech International AB· Forrás
Contact: Gönül Sonmez Utkun
Fut, nem toboroz
Riociguat in Children With Pulmonary Arterial Hypertension (PAH)
NCT02562235· 3. fázis· Bayer· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301
NCT06179875· 3. fázis· Viridian Therapeutics, Inc.· Forrás
Lezárult
An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)
NCT06021054· 3. fázis· Viridian Therapeutics, Inc.· Forrás
Lezárult
A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke
NCT05686070· 3. fázis· Bayer· Forrás
Toboroz
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
NCT05457283· 3. fázis· Bayer· Forrás
Lezárult
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)
NCT04846868· 3. fázis· Boehringer Ingelheim· Forrás
Lezárult
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
NCT03362177· 3. fázis· Amgen· Forrás
Lezárult
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
NCT03652064· 3. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
NCT02003924· 3. fázis· Pfizer· Forrás
Hibát jelzek